The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACCELERON PHARMA INC COM 00434H108 57,993 1,553,937 SH   SOLE   1,553,937 0 0
AKEBIA THERAPEUTICS INC COM 00972D105 37,128 1,887,535 SH   SOLE   1,887,535 0 0
ANAPTYSBIO INC COM 032724106 41,612 1,190,604 SH   SOLE   1,190,604 0 0
APOLLO ENDOSURGERY INC COM 03767D108 1,285 274,472 SH   SOLE   274,472 0 0
CORVUS PHARMACEUTICALS INC COM 221015100 51,710 3,244,046 SH   SOLE   3,244,046 0 0
CRISPR THERAPEUTICS AG NAMEN AKT H17182108 3,991 223,317 SH   SOLE   223,317 0 0
DERMIRA INC COM 24983L104 51,883 1,921,580 SH   SOLE   1,921,580 0 0
FLEXION THERAPEUTICS INC COM 33938J106 36,270 1,500,000 SH   SOLE   1,500,000 0 0
INOGEN INC COM 45780L104 337,540 3,549,320 SH   SOLE   3,549,320 0 0
INVUITY INC COM NEW 46187J205 12,138 1,363,848 SH   SOLE   1,363,848 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103 18,341 2,725,283 SH   SOLE   2,725,283 0 0
MERUS N V COM N5749R100 28,025 1,410,417 SH   SOLE   1,410,417 0 0
NABRIVA THERAPEUTICS PLC SHS G63637105 23,782 2,903,800 SH   SOLE   2,903,800 0 0
RA PHARMACEUTICALS INC COM 74933V108 29,661 2,031,562 SH   SOLE   2,031,562 0 0
REATA PHARMACEUTICALS INC CL A 75615P103 18,436 592,794 SH   SOLE   592,794 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106 11,370 740,740 SH   SOLE   740,740 0 0
WRIGHT MED GROUP N V RIGHT 03/01/2019 N96617126 7,164 4,622,032 PRN   SOLE   0 0 4,622,032